In-Home Sleep Diagnostics Now Available In Pekin, Il
Watermark Medical, the developer of the ARES (Apnea Risk Evaluation System) has recently contracted for services with local physician, Volkan Sumer, D.O., to offer the latest technology available for In-Home Sleep Diagnostics under the name of ICPR Family Practice, located at 1491 Valle Vista. Recently, as a result of studies, the Centers for Medicare and Medicaid Services (CMS) changed their national coverage determination to include these devices for home sleep testing for sleep disorders including obstructive sleep apnea.
‘”This marks a momentous step forward for the recognition of in-home sleep testing as an effective, cost-efficient means of diagnosing sleep-related illnesses,” said Dr. Sumer. “Thousands of people across Illinois aren’t being tested or treated because of the cost and inconvenience of overnight lab testing, and I am very excited to be in a position where we can now reach out to more physicians and patients to help and fight these debilitating disorders. We are taking a leadership position in increasing access for diagnosing sleep-related illnesses like sleep apnea, and it is my hope that if these conditions are diagnosed sooner, patients will receive treatment which could improve their quality of life.”
Sleep apnea, which affects over 10 million Americans and an estimated additional 10 million undiagnosed, is characterized by loud snoring interrupted by frequent episodes of totally obstructed breathing (obstructive sleep apnea). Serious episodes last more than 10 seconds each and occur more than seven times per hour. Apnea patients may experience 30 to 300 such events per night. These episodes can reduce blood oxygen levels, causing the heart to pump harder and over time, incur added risk levels for stroke and cardiac disorders. This new technology now offers patients a cost-effective, easy to use, and reliable device for the home diagnosis of obstructive sleep apnea, useful in diagnosing outcomes for the surgical and non-surgical treatment of obstructive sleep apnea in adults and children. More information can be found online at icpronline.com or by calling (309) 347-4277.
‘”This marks a momentous step forward for the recognition of in-home sleep testing as an effective, cost-efficient means of diagnosing sleep-related illnesses,” said Dr. Sumer. “Thousands of people across Illinois aren’t being tested or treated because of the cost and inconvenience of overnight lab testing, and I am very excited to be in a position where we can now reach out to more physicians and patients to help and fight these debilitating disorders. We are taking a leadership position in increasing access for diagnosing sleep-related illnesses like sleep apnea, and it is my hope that if these conditions are diagnosed sooner, patients will receive treatment which could improve their quality of life.”
Sleep apnea, which affects over 10 million Americans and an estimated additional 10 million undiagnosed, is characterized by loud snoring interrupted by frequent episodes of totally obstructed breathing (obstructive sleep apnea). Serious episodes last more than 10 seconds each and occur more than seven times per hour. Apnea patients may experience 30 to 300 such events per night. These episodes can reduce blood oxygen levels, causing the heart to pump harder and over time, incur added risk levels for stroke and cardiac disorders. This new technology now offers patients a cost-effective, easy to use, and reliable device for the home diagnosis of obstructive sleep apnea, useful in diagnosing outcomes for the surgical and non-surgical treatment of obstructive sleep apnea in adults and children. More information can be found online at icpronline.com or by calling (309) 347-4277.
Comments
Post a Comment